GlassScriptPhysician profile
Miranda A Goodale
NPI 1003858762
$479.31
in general payments reported to CMS, 2019-2025
9 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.89 · 2022: $24.45 · 2023: $35.10 · 2024: $15.04 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.66 |
| Travel and Lodging | $216.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $246.35 | 2024-2025 | |
| Stryker Corporation | $46.92 | 2025 | Citrefix |
| Kerecis Limited | $46.05 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $38.41 | 2025 | Physio-Stim |
| Globus Medical, INC. | $30.04 | 2025 | Senza |
| Paragon 28, INC. | $24.45 | 2022 | |
| Abbott Laboratories | $18.72 | 2025 | Proclaim |
| Smith+Nephew, INC. | $15.48 | 2023 | Collagenase Santyl |
| Organogenesis INC. | $12.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Goodale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.